Translate Bio Inc
TBIO · Other · NASDAQ · in our data June 28, 2018 to September 13, 2021 (3.2 years)
The first trading day in our data for Translate Bio Inc is June 28, 2018 (its first day in our records, which may be later than its listing and is not its founding). At its peak, on August 4, 2021, the market valued it at $2.9 billion. It left the market when it was bought or merged, last trading at $37.36, -1.3% from its split-adjusted high. Holders got whatever the deal paid, which is not in our price data.
Share prices are adjusted for splits and other share changes, so the high and the last price compare like for like; the peak market value is as it was on the day. The return covers the trading days in our data only: it does not include what holders received, or lost, after the last trade (a merger payout, a bankruptcy), and it does not reach back before 2018.
Play today's Daily DropAlso gone in 2021: Other
- P P D Inc peaked at $16.7 billion
- Eidos Therapeutics Inc peaked at $5.1 billion
- Pluralsight Inc peaked at $3.4 billion
- Constellation Pharmctcl peaked at $2.1 billion
- Amerant Bancorp Inc peaked at $1.1 billion
- Prevail Therapeutics Inc peaked at $795 million
